Registered business in FR. Official registry identity and a deliberately broad public benchmark curve on one indexed company profile.
CORALEXINE is shown here as a public net-asset reference from filed balance sheets. It is not an earnings-multiple valuation; owner or advisor data is needed for debt, asset quality, leases and marketability adjustments.
Broad benchmark based on comparable companies in this sector — not a company-specific appraisalOne public valuation range is currently available. A future eligible filing can extend this into a trend.
The historical value curve is public. Create a free account for the future five-year growth outlook, the insights behind it, and concrete action points that can increase this company’s value.
Free account · private workspace
Each step adds evidence that narrows the range. Public filings are a starting point. Connected accounts, owner context and method review make the valuation more useful for real decisions.
Own this company? Claim and manage the profileThis is a public asset-reference range, not an earnings-multiple valuation or a final transaction value. More accuracy requires owner or advisor context.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
CORALEXINE, a business in NACE sector 64.20, is registered at an address in France. The company was founded in 1998, incorporated as a 5710.
CORALEXINE is listed in French National Business Register (RNE/INPI) under registry number 421204421.
Public registry records place CORALEXINE in the French NACE 64.20 category.
CORALEXINE's public curve tracks a deliberately broad p10-p90 sector benchmark based on at least 30 comparable companies with stronger filed or size evidence. Its centre line is only the arithmetic middle of the published band: not a company-specific appraisal, sale price, offer, or recommendation.
It is a sector-level research range, not a company-specific appraisal, market value, asking price, offer, or investment recommendation.
CORALEXINE was founded in 1998 and is registered with French National Business Register (RNE/INPI), incorporated as a 5710.
CORALEXINE is registered under NACE 64.20: NACE 64.20. That places the business within the French cluster for this activity.
This page shows a rounded, automated indicative range generated by Upswitch from official registry facts, public company-size information, filed accounts where available, and governed sector benchmarks. The evidence basis is labelled beside the graph. It is not a certified or statutory valuation, sale price, offer, recommendation, or financial, investment, tax or legal advice. Figures for CORALEXINE may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
